The position of combined medical treatment in acromegaly
AUTOR(ES)
Coopmans, Eva C.
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
10/01/2020
RESUMO
ABSTRACT Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6):646-52
Documentos Relacionados
- Stereotactic treatment of acromegaly.
- Brazilian multicenter study on pegvisomant treatment in acromegaly
- Combined medical and surgical treatment of spinal hydatid disease: a case report.
- The Combined Treatment in Glaucoma
- Can telemedicine improve adherence to medical treatment? Lessons learned from research on acromegaly conducted during COVID-19 pandemic
